Johnson & Johnson Coronavirus (COVID-19) Updates
This section of the Johnson & Johnson Supplier Portal is where you can find up-to-date coronavirus (COVID-19) information.
Our Business Continuity Statement:
In our role as a global health leader, Johnson & Johnson is closely monitoring the COVID-19 (coronavirus) pandemic and taking steps to help prevent the spread of the virus as well as exploring the potential for a vaccine.
We have robust business continuity plans in place across our global supply chain network to prepare for unforeseen events and to meet the needs of the patients, customers and consumers who depend on our products. These steps include maintaining critical inventory at major distribution centers away from high-risk areas and working with external suppliers to support our preparedness plans.
The need for increased restrictions in some countries to help address the spread of the virus is presenting global supply chains with unprecedented logistical challenges; however, we are working closely with suppliers, distributors, local governments and regulators to continue to meet patient, customer and consumer need. We are closely monitoring product demand and supply levels across our global network to ensure adequate and effective distribution, and working to minimize delivery disruption to our customers who depend on us for timely delivery. We are also advising private and public customers to maintain normal ordering patterns where possible to avoid service delays, especially for those who rely on our critical medicines.
Below is a summary by sector:
Pharmaceutical: While this remains a dynamic situation, we do not foresee pharmaceutical supply interruptions related to COVID-19 at this time.
Medical Devices: While this remains a dynamic situation, we are not experiencing significant product supply interruptions related to COVID-19 at this time.
Consumer: We are experiencing increased consumer-driven demand with certain products and markets, which we are currently meeting in a controlled manner. We are taking all possible measures to maximize product availability.
As a leader in global health, our top priority remains our patients, customers and employees. We are partnering with global and local health authorities to address immediate and long-term health care needs, to ensure sustainable supply of our critical medicines, as well as to research potential vaccines and therapeutics.
We will remain on the front lines of this health crisis, bringing our full resources and minds to combat it.
Entering Johnson & Johnson affiliate facilities
Only business critical visitors are permitted to enter Johnson & Johnson affiliate facilities at this time. Please contract you Johnson & Johnson affiliate point of contact to confirm whether your visit qualifies as business critical. All visitors, contractors and external suppliers will be subject to restrictions for entering Johnson & Johnson affiliate facilities. Do not enter a Johnson & Johnson affiliate facility if you:
are exhibiting flu-like symptoms, or
have been in areas of high community transmission, or
·have been in close contact with someone infected or suspected of being infected
Travel Guidance for Suppliers
Suppliers who are planning a trip to Johnson & Johnson affiliate facilities should review Travel Health Notices from the Centers for Disease Control and Prevention before booking travel and check with your Johnson & Johnson affiliate point of contact.
Additional Resources
Real-time Confirmed Case Tracker by Johns Hopkins CSSE
World Health Organization (WHO) Latest Updates
Suppliers/contractors on remote work requirements
As the coronavirus (COVID-19) pandemic continues to expand in our region, the Johnson & Johnson Family of Companies are taking additional steps to protect our communities around the world and to ensure our facilities remain safe so we can continue to make critical medicines, devices and products for our patients and consumers.
We are committed to reducing face-to-face interactions where possible. Starting Friday, March 13 until further notice, we are issuing the following guidance for suppliers and contractors to reduce face-to-face interactions.
- Suppliers and contractors who can perform their job by working remotely should do so as of March 13, 2020.
- Suppliers and contractors who cannot perform their job by working remotely can continue to report to work at their site, if the site is open and not restricted to business-critical individuals.
- Reminders:
- We advise suppliers and contractors to work remotely for personal safety and prevent community spread
- If a supplier or contractor is unable to work remotely and their J&J affiliate work location is open, contractors should inform their J&J affiliate sponsor that they will come into the site to perform their job
- If a supplier or contractor is unable to work remotely and their J&J affiliate work location is open to only business critical workers, contractors should seek clarification from their J&J affiliate sponsor to be permitted to come into the site.
- Facilities are restricting access to anyone, including employees, suppliers, contractors and visitors, who is: exhibiting flu-like symptoms, has been in areas of high community transmission, or has been in close contact with someone infected or suspected of being infected.
- Suppliers and contractors with underlying medical conditions or other special circumstances, like people with COPD, other lung diseases, cancer, HIV etc., should work remotely at this time if they are in an area where there is COVID-19 and should contact their doctor. Their health and well-being come first.
Suppliers and contractors with questions on their report to work status should reach out to their employer or their WORKSENSE TM supplier management representative.
If a supplier or contactor has been potentially exposed to the virus, they should contact AskGS:
- North America: +17322204979
- EMEA: +3214788280
- LATAM: +5719272070
- ASPAC: +63279464646
How is the Coronavirus Transmitted?
According to the CDC, the virus is thought to spread mainly from person-to-person through droplets.
Respiratory droplets are produced when an infected person coughs or sneezes.
- Droplets can land in the mouths or noses of people who are nearby
- Respiratory droplets do not float in the air and may travel up to 2 meters (6 feet)
Respiratory droplets can land on a surface and then be transported to the nose, mouth or eye from your hands
- Depending on the type of material and conditions, the virus can live on a surface anywhere from a few hours to a few days.
Ensuring Your Health at Work – Guidance that has been provided to J&J Employees
- Reduce “close contact” (2 meters / ~ 6 feet for >10 minutes)
- Only essential staff onsite
- Spread out in common areas (cafeteria etc.)
- Modify operations to spread out staff, add barriers between staff
- Reduce face to face meetings and ensure space or social distancing
- Enhanced Cleaning
- Increasing the frequency of cleaning with approved products
- Focus on commonly touched surfaces (doors, common areas, restrooms, tables etc.)
- Keep people who are sick to stay home
- Continue to ensure people who are ill do not come to work
- Enhanced policies to ensure quarantined and ill employees are fully paid
- Safe Food Service
- Eliminating self-service options
- Adding pre-packaged food
According to the World Health Organization, Do the 5!
- Hands – Wash them often
- Elbow – Cough into it
- Face – Don’t touch it
- Space – Keep safe distance
- Home – Stay if you can
REMINDER: As business continuity plans are implemented related to COVID-19, please remember to follow change notification requirements as outlined in quality agreements, purchase order terms and conditions, or other agreements in order to ensure that appropriate qualification is completed in a timely manner.
If you anticipate having trouble meeting commitment dates on quality initiatives due to COVID-19, please contact your J&J quality representative in advance of the deadline in order to align on timing.